The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells.

Abstract

Estrogen is synthesized from cholesterol and high cholesterol levels are suggested to be associated with increased risk of estrogen receptor(ER)-positive breast cancer. The cholesterol metabolite 27-hydroxycholesterol (27-OHC) was recently identified as a selective estrogen receptor modulator (SERM) and may therefore impact breast cancer progression. However, the mechanisms by which 27-OHC may contribute to breast cancer are not all known. We determined the extent to which 27-OHC regulates cell proliferation in MCF7 ER-positive breast cancer cell line involving the tumor suppressor protein p53. We found that treatment of MCF7 cells with 27-OHC resulted reduced p53 transcriptional activity. Conversely, treatment of the ER-negative MDA-MB 231 cells with 27-OHC induced no significant change in p53 activity. Exposure of MCF7 cells to 27-OHC was also associated with increased protein levels of the E3 ubiquitin protein ligase MDM2 and decreased levels of p53. Moreover, 27-OHC also enhanced physical interaction between p53 and MDM2. Furthermore, 27-OHC-induced proliferation was attenuated using either the p53 activator Tenovin-1 or the MDM2 inhibitor Nutlin-3 and Mdm2 siRNA. Taken together, our results indicate that 27-OHC may contribute to ER-positive breast cancer progression by disrupting constitutive p53 signaling in an MDM2-dependent manner.

• Authors: Shaneabbas Raza, Joyce E Ohm, Archana Dhasarathy, Jared Schommer, Conor Roche, Kimberly D P Hammer, Othman Ghribi
• Journal: Molecular and cellular biochemistry (Mol Cell Biochem) Vol. 410 Issue 1-2 Pg. 187-95 (Dec 2015) ISSN: 1573-4919 [Electronic] Netherlands
• PMID: 26350565 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Acetanilides
• Hydroxycholesterols
• Imidazoles
• Piperazines
• Receptors, Estrogen
• Selective Estrogen Receptor Modulators
• TP53 protein, human
• Tumor Suppressor Protein p53
• nutlin 3
• 27-hydroxycholesterol
• tenovin-1
• MDM2 protein, human
• Proto-Oncogene Proteins c-mdm2
• Thiourea

Topics

• Acetanilides (pharmacology)
• Breast Neoplasms (enzymology, genetics, pathology)
• Cell Proliferation (drug effects)
• Dose-Response Relationship, Drug
• Female
• Gene Expression Regulation, Neoplastic
• Humans
• Hydroxycholesterols (pharmacology)
• Imidazoles (pharmacology)
• MCF-7 Cells
• Piperazines (pharmacology)
• Protein Binding
• Proto-Oncogene Proteins c-mdm2 (genetics, metabolism)
• RNA Interference
• Receptors, Estrogen (drug effects, metabolism)
• Selective Estrogen Receptor Modulators (pharmacology)
• Signal Transduction (drug effects)
• Thiourea (analogs & derivatives, pharmacology)
• Transcription, Genetic
• Transfection
• Tumor Suppressor Protein p53 (agonists, genetics, metabolism)